Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients

American Journal of Health-System Pharmacy

Volumn 64, Issue 19, 2007, Pages 2064-2068

  Heelon, Mark ^a   Skiest, Daniel ^b,c   Tereso, Gary ^d   Meade, Lauren ^d,e   Weeks, Julia ^d   Pekow, Penelope ^d,f   Rothberg, Michael B ^d,e  

^a BAYSTATE MEDICAL CENTER   (United States)

^b BAYSTATE HEALTH   (United States)

^c Community Research Initiative of New England ^*  (United States)

^d BMC   (Sweden)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Antiretroviral agents; Clinical pharmacists; Dosage; Drug interactions; Errors, medication; Formulations; HIV infections; Hospitals; Interventions; Rational therapy

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE;

ADULT; AGED; ARTICLE; DRUG FORMULATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PATIENT MONITORING; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; THERAPEUTIC ERROR; UNITED STATES;

EID: 34948854342     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070072     Document Type: Article

References (21)

1. Lesar TS, Lomaestro BM, Pohl H. Medication prescribing errors in a teaching hospital: a nine-year experience. Arch Intern Med. 1997; 157:1569-76.
2. Lesar TS, Briceland LL, Stein DL. Factors related to errors in medication prescribing. JAMA. 1997; 277:312-7.
3. Ong SW, Fermandes OA, Cesta A et al. Drug-related problems on hospital admission: relationship to medication information transfer. Ann Pharmacother. 2006; 40:408-12.
4. Cornish PL, Knowles SR, Marchesano R et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005; 165:424-9.
5. Gleason KM, Groszek JM, Sullivan C et al. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health-Syst Pharm. 2004; 61:1689-95.
6. Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis. 2006; 43:933-8.
7. Edelstein H, Wilson M. Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital. J Acquir Immun Defic Syndr. 2001; 28:496. Letter.
8. Purdy BD, Raymond AM, Lesar TS. ART prescribing errors in hospitalized patients. Ann Pharmacother. 2000; 34:833-8.
9. DeLorenze GN, Follansbee ST, Nguyen DP et al. Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care. 2005; 43(9 suppl):III63-8.
10. Ungvarski PJ, Rottner JE. Errors in prescribing HIV-1 protease inhibitors. J Assoc Nurses AIDS Care. 1997; 8:55-61.
11. Garey KW. Pharmacist intervention program for hospitalized patients with HIV infection. Am J Health-Syst Pharm. 2000; 57:2283-4.
12. National Institutes of Health. Guidelines for the use of ART agents in HIV-1-infected adults and adolescents. www.AIDSinfo.nih.gov (accessed 2006 Oct 3).
13. Frost DW, Nijhuis M, Schuurman R et al. Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection. J Virol. 2000; 74:6262-8.
14. Richman DD, Havlir D, Corbeil J et al. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol. 1994; 68:1660-6.
15. Harrigan PR, Hogg RS, Dong WW et al. Predictors of HIV drug resistance mutations in a large ART-naïve cohort initiating triple ART therapy. J Infect Dis. 2005; 191:339-47.
16. Wainberg MA, Friedland G. Public health implications of ART therapy and HIV drug resistance. JAMA. 1998; 279:1977-83.
17. Mutnick AH, Sterba KJ, Peroutka JA et al. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm. 1997; 54:392-6.
18. Kaboli PJ, Hoth AB, McClimon BJ et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166:955-64.
19. Bozek PS, Perdue BE, Bar-Din M et al. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health-Syst Pharm. 1998; 55:1151-5.
20. De Maat MM, de Boer A, Koks CH et al. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther. 2004; 29:121-30.
21. Lee AJ, Boro MS, Knapp KK et al. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health-Syst Pharm. 2002; 59:2070-7.